Open Heart
(Jun 2022)
Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
- Pankaj Garg,
- Graham Fent,
- Andrew J Swift,
- Abdallah Al-Mohammad,
- Nigel Lewis,
- Dominic Rogers,
- Athanasios Charalampopoulos,
- Elena Wolodimeroff
Affiliations
- Pankaj Garg
- Cardiology, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
- Graham Fent
- Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK
- Andrew J Swift
- Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK
- Abdallah Al-Mohammad
- consultant cardiologist
- Nigel Lewis
- IICD, The University of Sheffield, Sheffield, UK
- Dominic Rogers
- Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Athanasios Charalampopoulos
- Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Elena Wolodimeroff
- Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield Medical School, Sheffield, UK
- DOI
-
https://doi.org/10.1136/openhrt-2022-001974
- Journal volume & issue
-
Vol. 9,
no. 1
WeChat QR code